ALIMERA SCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.48 USD | +0.58% |
|
+5.14% | -19.44% |
Chart calendar Alimera Sciences, Inc.
4a07dbf13a5d4f9b05b466b906264.fIuRBLq2T5VKc04GN0JwHP6To0tpJaBy9gLy_WkOfGs.BfK8VP7sd6MMMgttUC49WI7n2ikRbMsglEaZyCA7Oj9Rzuc0is49ox8HGw~f082c2eabc57d11cf52ceb0ab1d878b3
Upcoming events on Alimera Sciences, Inc.
Past events on Alimera Sciences, Inc.
| 2024-04-29 | Q1 2024 Earnings Release (Projected) |
| 2024-03-07 09:00 am | Q4 2023 Earnings Call |
| 2024-03-07 07:30 am | Q4 2023 Earnings Release |
| 2023-11-05 07:45 pm | American Academy Of Ophthalmology Meeting |
| 2023-11-02 | American Academy Of Ophthalmology Meeting - David Chin-Yee |
| 2023-11-02 | American Academy Of Ophthalmology Meeting - Mathew MacCumber |
| 2023-11-02 | American Academy Of Ophthalmology Meeting - Daniel Kiernan |
| 2023-10-26 09:00 am | Q3 2023 Earnings Call |
| 2023-10-26 07:00 am | Q3 2023 Earnings Release |
| 2023-10-13 02:43 pm | The Retina Society Scientific Meeting |
| 2023-10-13 02:40 pm | The Retina Society Scientific Meeting |
| 2023-10-13 02:34 pm | The Retina Society Scientific Meeting |
| 2023-10-13 02:30 pm | The Retina Society Scientific Meeting |
| 2023-10-11 04:17 pm | The Retina Society Scientific Meeting |
| 2023-09-11 11:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-10 09:00 am | Q2 2023 Earnings Call |
| 2023-08-10 07:30 am | Q2 2023 Earnings Release |
| 2023-08-01 09:30 am | Annual General Meeting |
| 2023-05-18 08:30 am | Business Update Call |
| 2023-05-15 07:50 am | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 53,9 51,6 4.56% | 50,8 50,0 1.55% | 59,0 54,8 7.71% | 54,1 54,7 -1.01% | 80,8 78,8 2.45% | 104 |
|
EBITDA Million USD | Released Forecast Spread | 0,02 -1,27 101.66% | 3,49 3,81 -8.27% | 0,00 0,00 - | 0,00 0,00 - | 8,71 9,20 -5.32% | 21,2 |
|
EBIT Million USD | Released Forecast Spread | -5,27 -7,22 26.9% | -0,50 -0,11 -339.47% | -0,20 0,89 -122.71% | -11,6 -10,6 -10% | -1,93 -0,61 -219.34% | 8,04 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,2 -12,9 20.47% | -5,41 -4,41 -22.62% | -3,93 -2,71 -45.01% | -18,1 -16,6 -8.62% | -20,0 -13,4 -49.1% | -0,48 |
|
Net income Million USD | Released Forecast Spread | -10,4 -13,0 19.89% | -5,34 -4,78 -11.64% | -4,37 -3,20 -36.69% | -18,1 -16,7 -8.69% | -21,4 -13,1 -63.37% | -0,48 |
|
EPS USD | Released Forecast Spread | -2,19 -2,74 19.96% | -1,04 -0,91 -13.87% | -0,66 -0,47 -40.43% | -2,59 -2,39 -8.6% | -0,79 -0,56 -40.24% | -0,01 |
| Announcement Date | 26/02/20 | 24/02/21 | 24/02/22 | 31/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 14,0 13,4 4.13% | 11,9 12,9 -7.77% | 14,6 13,1 11.17% | 13,6 15,0 -9.63% | 14,0 14,6 -4.02% | 13,5 12,3 10.13% | 17,5 20,5 -14.24% | 23,4 22,7 2.85% | 26,3 24,3 8.06% | 22,3 | 25,2 | 26,9 | 29,4 | 25,8 |
|
EBITDA Million USD | Released Forecast Spread | -2,40 -3,20 25.16% | 0,87 1,20 -27.17% | 5,42 2,20 146.27% | 5,03 4,90 2.65% | 2,01 | 4,45 | 5,92 | 8,83 | 3,60 | |||||
|
EBIT Million USD | Released Forecast Spread | -2,75 -1,64 -67.75% | -4,15 -3,51 -18.15% | -1,97 -3,35 40.99% | -3,41 -1,46 -134.27% | -2,11 -1,07 -97.84% | -3,30 -3,42 3.38% | -1,21 1,93 -162.75% | 1,85 0,91 104.75% | 0,72 2,06 -64.77% | -0,97 | 1,22 | 2,52 | 5,30 | 0,50 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,14 -2,92 -41.97% | -5,96 -4,79 -24.32% | -3,10 -4,68 33.73% | -5,25 -2,79 -88.26% | -3,78 -2,35 -61.2% | -4,97 -4,80 -3.58% | -10,0 -0,06 -17000.85% | -1,30 -0,78 -67.22% | -3,77 -0,90 -319.33% | -3,11 | -0,93 | 0,37 | 3,16 | -1,80 |
|
Net income Million USD | Released Forecast Spread | -4,11 -2,92 -40.83% | -5,96 -4,79 -24.32% | -3,12 -4,68 33.37% | -5,26 -2,79 -88.69% | -3,78 -2,35 -61.16% | -4,98 -4,80 -3.87% | -10,7 -0,06 -18187.18% | -1,93 -0,78 -148.07% | -3,78 -0,90 -320.11% | -3,11 | -0,93 | 0,37 | 3,16 | -1,80 |
|
EPS USD | Released Forecast Spread | -0,59 -0,42 -40.48% | -0,85 -0,69 -23.19% | -0,45 -0,67 32.84% | -0,75 -0,40 -87.5% | -0,54 -0,34 -61.19% | -0,71 -0,52 -37.86% | -1,32 0,01 -26500% | -0,06 0,12 -150% | -0,07 0,00 - | -0,06 | -0,01 | 0,01 | 0,06 | -0,03 |
| Announcement Date | 24/02/22 | 09/05/22 | 27/07/22 | 14/11/22 | 31/03/23 | 15/05/23 | 10/08/23 | 26/10/23 | 07/03/24 | - | - | - | - | - |
| 2024-05-06 07:00 am | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-06 | BIOTEST AG: Q1 2024 Earnings Release |
| 2024-05-06 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | REVANCE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-07 02:00 am | BIOGAIA AB: Q1 2024 Earnings Release |
| 2024-05-07 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 | INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-07 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
Past sector events for Alimera Sciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALIM Stock
- Calendar Alimera Sciences, Inc.
